Cargando…
Zolpidem Use and the Risk of Injury: A Population-Based Follow-Up Study
BACKGROUND: While an association between zolpidem use and fracture and road accident was previously proposed, this study aimed to further explore the frequency and risk of a wide spectrum of injuries in subjects prescribed with zolpidem in Taiwan. METHODS: We identified 77,036 subjects who received...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3694900/ https://www.ncbi.nlm.nih.gov/pubmed/23826304 http://dx.doi.org/10.1371/journal.pone.0067459 |
_version_ | 1782274911691079680 |
---|---|
author | Chung, Shiu-Dong Lin, Ching-Chun Wang, Li-Hsuan Lin, Herng-Ching Kang, Jiunn-Horng |
author_facet | Chung, Shiu-Dong Lin, Ching-Chun Wang, Li-Hsuan Lin, Herng-Ching Kang, Jiunn-Horng |
author_sort | Chung, Shiu-Dong |
collection | PubMed |
description | BACKGROUND: While an association between zolpidem use and fracture and road accident was previously proposed, this study aimed to further explore the frequency and risk of a wide spectrum of injuries in subjects prescribed with zolpidem in Taiwan. METHODS: We identified 77,036 subjects who received Zolpidem treatment between 2005 and 2007. We randomly selected 77,036 comparison subjects who were frequency-matched based-on their demographic profiles. We individually tracked each subject for a 90-day period to identify those who subsequently suffered an injury. Cox proportional hazards regressions were performed to calculate the hazard ratio of injury between the two groups. RESULTS: The incidence rate of injury during the 90-day follow-up period for the total subjects was 18.11 (95% CI = 17.69–18.54) per 100 person-years; this was 24.35 (95% CI = 23.66–25.05) and 11.86 (95% CI = 11.39–12.36) for the study and comparison cohort, respectively. After adjusting for demographic variables, the hazard ratio (HR) of injury during the 90-day follow-up period for study subjects was 1.83 (95% CI = 1.73–1.94) that of comparison subjects. Additionally, compared to comparison subjects, the adjusted HR of injury during the 90-day follow-up period for study subjects who were prescribed Zolpidem for >30 days was as high as 2.17 (95% CI = 2.05–2.32). The adjusted HR of injury to blood vessels for study subjects was particularly high when compared to comparison subjects (HR = 6.34; 95% CI = 1.37–29.38). CONCLUSIONS: We found that patients prescribed with Zolpidem were at a higher risk for a wide range of injuries. |
format | Online Article Text |
id | pubmed-3694900 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-36949002013-07-03 Zolpidem Use and the Risk of Injury: A Population-Based Follow-Up Study Chung, Shiu-Dong Lin, Ching-Chun Wang, Li-Hsuan Lin, Herng-Ching Kang, Jiunn-Horng PLoS One Research Article BACKGROUND: While an association between zolpidem use and fracture and road accident was previously proposed, this study aimed to further explore the frequency and risk of a wide spectrum of injuries in subjects prescribed with zolpidem in Taiwan. METHODS: We identified 77,036 subjects who received Zolpidem treatment between 2005 and 2007. We randomly selected 77,036 comparison subjects who were frequency-matched based-on their demographic profiles. We individually tracked each subject for a 90-day period to identify those who subsequently suffered an injury. Cox proportional hazards regressions were performed to calculate the hazard ratio of injury between the two groups. RESULTS: The incidence rate of injury during the 90-day follow-up period for the total subjects was 18.11 (95% CI = 17.69–18.54) per 100 person-years; this was 24.35 (95% CI = 23.66–25.05) and 11.86 (95% CI = 11.39–12.36) for the study and comparison cohort, respectively. After adjusting for demographic variables, the hazard ratio (HR) of injury during the 90-day follow-up period for study subjects was 1.83 (95% CI = 1.73–1.94) that of comparison subjects. Additionally, compared to comparison subjects, the adjusted HR of injury during the 90-day follow-up period for study subjects who were prescribed Zolpidem for >30 days was as high as 2.17 (95% CI = 2.05–2.32). The adjusted HR of injury to blood vessels for study subjects was particularly high when compared to comparison subjects (HR = 6.34; 95% CI = 1.37–29.38). CONCLUSIONS: We found that patients prescribed with Zolpidem were at a higher risk for a wide range of injuries. Public Library of Science 2013-06-27 /pmc/articles/PMC3694900/ /pubmed/23826304 http://dx.doi.org/10.1371/journal.pone.0067459 Text en © 2013 Chung et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Chung, Shiu-Dong Lin, Ching-Chun Wang, Li-Hsuan Lin, Herng-Ching Kang, Jiunn-Horng Zolpidem Use and the Risk of Injury: A Population-Based Follow-Up Study |
title | Zolpidem Use and the Risk of Injury: A Population-Based Follow-Up Study |
title_full | Zolpidem Use and the Risk of Injury: A Population-Based Follow-Up Study |
title_fullStr | Zolpidem Use and the Risk of Injury: A Population-Based Follow-Up Study |
title_full_unstemmed | Zolpidem Use and the Risk of Injury: A Population-Based Follow-Up Study |
title_short | Zolpidem Use and the Risk of Injury: A Population-Based Follow-Up Study |
title_sort | zolpidem use and the risk of injury: a population-based follow-up study |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3694900/ https://www.ncbi.nlm.nih.gov/pubmed/23826304 http://dx.doi.org/10.1371/journal.pone.0067459 |
work_keys_str_mv | AT chungshiudong zolpidemuseandtheriskofinjuryapopulationbasedfollowupstudy AT linchingchun zolpidemuseandtheriskofinjuryapopulationbasedfollowupstudy AT wanglihsuan zolpidemuseandtheriskofinjuryapopulationbasedfollowupstudy AT linherngching zolpidemuseandtheriskofinjuryapopulationbasedfollowupstudy AT kangjiunnhorng zolpidemuseandtheriskofinjuryapopulationbasedfollowupstudy |